Sort
21,453 grants matching “tuberculosis”
Chemical probes of vulnerable pathways in antibiotic-resistant pathogens
$747,835Tanya Parish · Access To Advanced Health Institute · R01 · FY2012 · AI
Chemical biology studies of MmpL3 inhibition and resistance in mycobacteria
$747,825Robert B Abramovitch · Michigan State University · R01 · FY2024 · AI
Treating Sleep Apnea in Type 2 Diabetes Mellitus: A Randomized Clinical Trial
$747,774Naresh Punjabi · Johns Hopkins University · R01 · FY2014 · HL
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
$747,759Abraham Pinter · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
$747,745Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$747,678Kathleen Powis · Massachusetts General Hospital · R01 · FY2021 · AI
Host-directed therapy of tuberculosis: Rescuing macrophages and enhancing their activation
$747,665Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI
Host-directed therapy of tuberculosis: Rescuing macrophages and enhancing their activation
$747,665Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Host-directed therapy of tuberculosis: Rescuing macrophages and enhancing their activation
$747,665Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
$747,406David J. Horne · University Of Washington · R01 · FY2023 · AI
IgM in the regulation of TB immunity
$747,370John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
$747,342Abraham Pinter · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
$747,342Abraham Pinter · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr
$747,226Kirill Ostanin · Navigen, Inc. · R44 · FY2014 · AR
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$747,173Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis
$747,157Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2024 · AI
Macaque Models of AIDS-Related Tuberculosis and T Cell
$746,953University Of Illinois At Chicago · R01 · FY2005 · HL
Task A19: In Vitro Assessment of Anti-Microbial Activity
$746,950Tanya Parish · Access To Advanced Health Institute · N01 · FY2015 · AI
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
$746,671Shabaana A. Khader · Washington University · R01 · FY2016 · AI
Novel therapeutics to treat TB by stimulating bacterial cAMP production
$746,602Brian C Vanderven · Cornell University · R01 · FY2025 · AI
Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infection
$746,475Ryan C Bailey · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Developmental Core (Core B)
$746,336John Koethe · Vanderbilt University Medical Center · P30 · FY2022 · AI
Center for Humanized Mice
$746,325Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2016 · OD
Exploratory Chemistry on a new antibiotic
$746,210Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2016 · AI
Project 2: Response to Treatment
$746,072David R Sherman · Seattle Children'S Hospital · U19 · FY2022 · AI